- NASP Comments on Health and Human Services (HHS) Request for Information (RFI) on Regulatory Relief to Support Economic Recovery Dec 28, 2020 The National Association of Specialty Pharmacy (NASP) is pleased to provide comments in response to the... read more
- Summary on the U.S. Supreme Court’s Opinion on Rutledge v. PCMA Dec 10, 2020 WASHINGTON, DC (December 10, 2020) – Today, the United States Supreme Court issued its opinion in... read more
- Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients Nov 24, 2020 WASHINGTON, DC (November 24, 2020) – Today the country’s leading pharmacy groups issued this statement on... read more
- NASP Supports the SAFE TO WORK ACT Jul 30, 2020 WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jul 29, 2020 WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- NASP Submits Comments to CMS Jul 23, 2020 WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
- NASP submits comments to CMS on CMS-1744-IFC Jun 01, 2020 WASHINGTON, DC (June 1, 2020) – Please click here to read NASP’s comments submitted Monday, June... read more
- More than ¼ of the House of Representatives Call for Pharmacy DIR Reform Action Now Apr 27, 2020 WASHINGTON, DC (April 27, 2020) – With the help of the National Association of Specialty Pharmacy,... read more
- BiPartisan Support for DIR Reform in Next Congressional Stimulus Bill Apr 14, 2020 WASHINGTON, DC (April 14, 2020) – A bipartisan group of House Members of Congress is leading... read more
- NASP submits Comments to CMS on the 2021 and 2022 Proposed Rule Apr 07, 2020 WASHINGTON, DC (April 7, 2020) – Please click here to read NASP’s comments submitted Monday, April... read more